GRACE ONCOLOGY
PERSONALIZED CANCER TREATMENT
Billions of dollars are spent by pharmaceutical companies in search of future “blockbuster” chemotherapy drugs. Unfortunately, this doesn’t help the cancer patient who requires treatment today.
In fact, many good chemotherapy drugs already exist. However, none of these drugs is a universal magic bullet. Instead, some drugs benefit some patients while different drugs benefit others. There is no “best” drug for all patients with the same type of cancer.
Therefore, the greatest success in treating cancer right now - not in the future - can be achieved by using existing chemotherapy drugs more effectively. The best way to accomplish this is to personalize treatment for each patient. Dr. Grace has dedicated himself and his medical practice to precisely this approach.
Dr. Grace’s advocacy of personalized cytometric profiling began more than 30 years ago. Over the past decade Dr. Grace has collaborated closely with Larry Weisenthal, MD, Ph.D.. (Please note that this is a professional collaboration only - there is no business connection between Dr. Weisenthal’s laboratory-based medical practice and Grace Oncology.) Dr. Weisenthal is a medical oncologist and career cancer researcher. He is generally acknowledged to be the preeminent authority in developing and performing personalized cytometric profiling tests. His contributions to the field span more than 35 years and include originating what has become the gold-standard cytometric profiling technology.
At his facility in Huntington Beach, California, Dr. Weisenthal will personally perform laboratory analysis of your living cancer cells. If your would like to know more about how your cytometric profiling tests will be performed, please click here.
Dr. Grace will then interpret your personalized profiling test results. The ability to utilize cytometric profiling data in the design of highly effective, personalized chemotherapy treatments requires a thorough understanding of the theoretical and practical capabilities and limitations of the tests. Another key requirement is familiarity with the extensive body of medical literature that supports the accuracy of these tests in the correct hands. A third indispensable element is experience in using the tests for actual patient treatment. Your test data must be viewed in light of your specific clinical situation, your treatment history, and your physical condition. Known mechanisms of drug activity and interactions of candidate drugs must also be taken into consideration.
Dr. Grace is recognized by cytometric profiling authorities as one of the world’s foremost experts in the art and science of designing and administering personalized chemotherapy treatments in conjunction with cytometric profiling data. In this emerging discipline, few physicians worldwide have achieved Dr. Grace’s level of experience and treatment success.
